Geode Capital Management LLC Grows Stock Holdings in Evolus, Inc. (NASDAQ:EOLS)

Geode Capital Management LLC grew its holdings in Evolus, Inc. (NASDAQ:EOLS) by 0.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,210,621 shares of the company’s stock after buying an additional 11,027 shares during the period. Geode Capital Management LLC’s holdings in Evolus were worth $19,616,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Quest Partners LLC purchased a new position in shares of Evolus in the 2nd quarter worth approximately $43,000. Quarry LP bought a new stake in shares of Evolus in the 2nd quarter worth about $54,000. Profund Advisors LLC purchased a new position in shares of Evolus during the 2nd quarter worth about $130,000. Point72 Asset Management L.P. bought a new position in Evolus during the 3rd quarter valued at about $132,000. Finally, Arizona State Retirement System raised its holdings in shares of Evolus by 9.4% in the second quarter. Arizona State Retirement System now owns 14,603 shares of the company’s stock worth $158,000 after buying an additional 1,253 shares during the period. 90.69% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

EOLS has been the subject of a number of recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating on shares of Evolus in a research note on Monday, September 16th. Barclays increased their target price on shares of Evolus from $16.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, September 13th. Needham & Company LLC restated a “buy” rating and issued a $22.00 price target on shares of Evolus in a report on Friday, September 13th. Finally, HC Wainwright reissued a “buy” rating and set a $27.00 price objective on shares of Evolus in a report on Thursday, November 7th.

Evolus Price Performance

Shares of EOLS stock opened at $11.09 on Friday. The stock’s 50-day moving average is $13.35 and its 200 day moving average is $13.73. Evolus, Inc. has a 1-year low of $9.80 and a 1-year high of $17.82. The company has a debt-to-equity ratio of 20.58, a current ratio of 2.47 and a quick ratio of 2.23. The company has a market cap of $702.23 million, a P/E ratio of -12.19 and a beta of 1.27.

Evolus Profile

Evolus, Inc, a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.